CFD and neoplasm: In PyVT(+/−)/ADN(+/−) tumor cells, the TrxR1 promoter-driven reporter activity was ∼1.8 fold higher than that of PyVT(+/−)/ADN(+/+) tumor cells (Figure 9D).